Table 1 Clinical and biological characteristics of participants
Variables | N (%) or Mean (SD) |
|---|---|
N (%) | 163 (100) |
Female gender, n (%) | 101 (62) |
Age, Mean (SD), years | 57.7 (10.4) |
HTN medication, n (%) | 148 (90.8) |
Tobacco consumption, n (%) | 3 (1.8) |
Alcohol consumption, n (%) | 37 (22.7) |
Sedentary lifestyle, n (%) | 73 (44.8) |
Known dyslipidemia, n (%) | 7 (4.3) |
Familial history of CV events, n (%) | 43 (26.4) |
Vascular complications, n (%) | 25 (15.3) |
Comorbidities, n (%) | 40 (24.5) |
Systolic BP (SD), mmHg | 150 (21.9) |
Diastolic BP (SD), mmHg | 95.2 (13.1) |
BMI (SD), Kg/m2 | 29.2 (4.8) |
WC (SD), cm | 100.2 (11.6) |
Metabolic syndrome | 61 (37.4) |
Glycaemia (SD), g/L | 0.86 (0.13) |
HDL cholesterol (SD), g/L | 0.49 (0.14) |
LDL cholesterol (SD), g/L | 1.12 (0.45) |
Total Cholesterol (SD), g/L | 1.79 (0.44) |
Triglycerides (SD), g/L | 0.82 (0.40) |
GGT (SD), U/L | 29.3 (11.7) |
ALT (SD), U/L | 17 (9.3) |
Serum albumin (SD), g/L | 42.6 (2.6) |
Uricemia (SD), mg/L | 54.7 (16.3) |
hsCRP (SD), mg/L | 1.6 (1.29) |